Get my own profile
Public access
View all72 articles
3 articles
available
not available
Based on funding mandates
Co-authors
- Irene GhobrialDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
- Aldo RoccaroASST Spedali Civili di Brescia, Brescia, ItalyVerified email at asst-spedalicivili.it
- Barbara MuzSenior Scientist, WUGENVerified email at wugen.com
- Pilar de la PuenteSanford Research. Cancer Biology and ImmunotherapiesVerified email at sanfordhealth.org
- Charles LinMassachusetts General Hospital, Harvard Medical SchoolVerified email at hms.harvard.edu
- Michaela ReaganMaine Health Institute for ResearchVerified email at mainehealth.org
- Noha Nabil SalamaCairo University Faculty of Pharmacy and St. Louis College of PharmacyVerified email at pharma.cu.edu.eg
- Samuel AchilefuUniversity of Texas Southwestern Medical Center, DallasVerified email at UTSouthwestern.edu
- Kinan AlhallakNortheastern UniversityVerified email at northeastern.edu
- Abraham (Avri) RubinsteinProfessor of Phramceutical Sciences, The Hebrew University of JerusalemVerified email at ekmd.huji.ac.il
- James D GriffinDana-Farber Cancer InstituteVerified email at dfci.harvard.edu
- Michele Moschetta, MD PhDExecutive Director, Early Clinical Development Oncology, AstraZenecaVerified email at astrazeneca.com
Follow
Abdel Kareem Azab
Associate Professor, Biomedical Engineering, University of Texas Southwestern Medical Center
Verified email at utsouthwestern.edu - Homepage